Bayer Completes Acquisition of Perfuse Therapeutics
Bayer has completed the acquisition of Perfuse Therapeutics, strengthening its ophthalmology pipeline and expanding its portfolio of innovative eye disease treatments.
Bayer Pharmaceuticals | 19/06/2026 | By News Bureau
WHO and Bayer Renew Partnership to Combat NTDs
The World Health Organization (WHO) and Bayer AG have renewed their partnership to combat Chagas disease, sleeping sickness, and taeniasis, with Bayer pledging USD 9.45 million to support WHO’s efforts through 2030.
Bayer Pharmaceuticals | 06/11/2025 | By Dineshwori | 304
Bayer Acquires Zydus Pharma with Full Ownership
Bayer Pharmaceuticals Private Ltd. and Zydus Lifesciences Ltd. have announced the successful conclusion of their joint venture (JV) - Bayer Zydus Pharma Private Ltd. (BZPPL).
Bayer Pharmaceuticals | 03/05/2024 | By Aishwarya | 1219
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy